Huiling Lai

A novel diagnostic nomogram based on serological and ultrasound findings for preoperative prediction of malignancy in patients with ovarian masses.

Hong-wei Shen, Weipeng He, Z. You, 2020, Gynecologic oncology.

CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2

D. Xie, Weipeng He, Guiyun Yang, 2020, International journal of medical sciences.

SLC11A2: a promising biomarker and therapeutic target in ovarian cancer

Xia Li, S. Yao, Y. Ren, 2023, Scientific Reports.

Non-target genetic manipulation induces rhabdomyosarcoma in KrasPten-driven mouse model of ovarian cancer

Yuanyuan Li, Weipeng He, Z. You, 2020, Translational cancer research.

Protein Panel of Serum-Derived Small Extracellular Vesicles for the Screening and Diagnosis of Epithelial Ovarian Cancer

Y. Ren, Shasha He, Weipeng He, 2022, Cancers.

Necroptosis‐related regulatory pattern and scoring system for predicting therapeutic efficacy and prognosis in ovarian cancer

Linxiang Wu, Huiling Lai, Shuqin Chen, 2023, Cancer reports.